Wearable Oscillation Harness With Disposable Shields For Respiratory Therapy

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current respiratory therapy systems for patients with conditions like COPD and cystic fibrosis face challenges in effectively clearing airway secretions, monitoring compliance with treatment regimens, and preventing cross-contamination between users, particularly in home-based rehabilitation settings.

Innovation Solution

A system comprising a wearable harness with adjustable oscillation engines and shields to inhibit contamination, along with a controller for monitoring effective use, ensures proper secretion mobilization and compliance tracking while preventing cross-contamination through impermeable and antimicrobial materials.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If a wearable harness with oscillation engines is reused across multiple patients, then productivity and cost-effectiveness improve, but cross-contamination risk increases

Engineering Contradiction:
Improvedevice reuse efficiencyVSAvoidcross-contamination risk
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The system divides the wearable harness into separable components: a reusable outer harness and disposable inner liners/shields. This segmentation allows the main structure to be reused while the contamination-prone parts are discarded after single use, resolving the contradiction between productivity and contamination risk.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent implements disposable inner liners and shields that are discarded after single use. These low-cost, single-use components protect the expensive reusable oscillation engines and harness structure from contamination, enabling device reuse while eliminating cross-contamination risks.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

2Object-affected harmful factors

If shields and disposable components are added to prevent contamination, then cross-contamination risk decreases, but device complexity increases

Engineering Contradiction:
Improvecross-contamination riskVSAvoidsystem structure complexity
Core Design Contradiction:
Object-affected harmful factorsVSDevice complexity

Solution Approach 1:

The harness is segmented into modular components (outer harness, inner liners, shields) that can be independently assembled and disposed of. This modular approach manages complexity by making each component simple while the system as a whole achieves contamination protection.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The disposable inner liners and shields serve multiple functions: they protect against cross-contamination, provide a barrier during oscillation therapy, and can be easily attached/detached. This multi-functionality reduces the need for additional separate components, managing overall system complexity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Reliability

If compliance monitoring is implemented, then treatment efficacy improves, but device complexity increases

Engineering Contradiction:
Improvetreatment complianceVSAvoidmonitoring system complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The controller provides feedback to the patient about their compliance with the treatment regimen. This feedback mechanism motivates patients to follow the prescribed therapy schedule, improving treatment efficacy without requiring complex external monitoring systems.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The compliance monitoring system is integrated into the device itself, allowing it to automatically track and report usage data. This self-service approach eliminates the need for separate monitoring equipment or manual tracking, managing complexity while maintaining reliability.

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The system effectively mobilizes airway secretions, tracks patient compliance, and reduces cross-contamination risks, enhancing treatment efficacy and safety in home-based settings.

Implementation Method 1

High frequency chest wall oscillation (HFCWO) creates high velocity, low amplitude oscillation energy when applied through a vest worn over the thorax

Methodology Applied
Scientific EffectHigh frequency chest wall oscillation: Vibration

Implementation Method 2

A first shield may be positioned on a torso of a subject. The first shield may inhibit transmission of contaminants through the first shield

Methodology Applied
Scientific EffectPhysical barrier inhibition: Physical Containment

Data Source

PatentEP3863588B1Systems and methods for effective reuse of a selfcontained portable positionable oscillating motor array
Publication Date: 2023.12.06 TACTILE SYSTEMS TECHNOLOGY INC
  • EP3863588B1 patent drawingFigure 1~2
  • EP3863588B1 patent drawingFigure 3
  • EP3863588B1 patent drawingFigure 4A~4B

AI summary

In some embodiments, a method may include inhibiting contamination of a medical device. The method may include positioning a first shield on a torso of a subject. The first shield may inhibit transmission of solid and fluid contaminants. The method may include positioning a wearable harness of a medical device on a torso of a first subject. The method may include positioning a second shield on a torso of a subject such that the wearable harness is positioned, during use, between the first shield and the second shield. The second shield may inhibit transmission of solid and fluid contaminants. The method may include applying an oscillation force to at least one of the treatment areas using at least some of a plurality of engines coupled to the wearable harness. The method may include mobilizing at least some secretions in an airway within the subject substantially adjacent to the treatment areas.